(19)
(11)EP 3 184 640 A3

(12)EUROPEAN PATENT APPLICATION

(88)Date of publication A3:
06.12.2017 Bulletin 2017/49

(43)Date of publication A2:
28.06.2017 Bulletin 2017/26

(21)Application number: 17152652.8

(22)Date of filing:  30.05.2011
(27)Previously filed application:
 30.05.2011 PCT/EP2011/058864
(51)International Patent Classification (IPC): 
C12N 15/82(2006.01)
C07K 14/415(2006.01)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)Priority: 28.05.2010 US 349655 P
13.08.2010 EP 10382231

(62)Application number of the earlier application in accordance with Art. 76 EPC:
11723923.6 / 2576797

(71)Applicant: Zera Intein Protein Solutions, S.L.
08034 Barcelona (ES)

(72)Inventors:
  • MARZÁBAL LUNA, Pablo
    08027 Barcelona (ES)
  • LLOP, Mª Inmaculada
    08980 St. Feliu de Llobregat (ES)
  • LUDEVID MUGICA, María Dolores
    08960 Sant Just Desvern (ES)
  • LLOMPART ROYO, Blanca
    08011 Barcelona (ES)
  • MINU, Joseph
    08226 Terrasa (ES)
  • TORRENT QUETGLAS, Margarita
    08023 Barcelona (ES)
  • BASTIDA VIRGILI, Miriam
    08750 Molins de Rei (ES)

(74)Representative: ABG Patentes, S.L. 
Avenida de Burgos, 16D Edificio Euromor
28036 Madrid
28036 Madrid (ES)

  


(54)PROTEIN BODY-INDUCING POLYPEPTIDE SEQUENCES


(57) Polypeptide sequences for inducing recombinant protein bodies are described. The sequences comprise a polyproline II (PPII) structure between two cysteine residues on either end and an ER signal sequence Recombinant protein bodies are useful for protein production because they allow for simple and efficient purification of high quantities of recombinant protein. In addition, other methods of using recombinant protein bodies, for example, in vaccination, are also described.







Search report




































Search report